After suffering from timing issues in inaugurating its factory in Cleveland, Ohio, Denmark's Xellia Pharmaceuticals has finally started production at its new facility, Xellia informs in a press statement after the firm shipped the first batch of antibiotics made at the plant, with sales directed at US hospitals.
"Xellia Cleveland is now commercially operational thanks to the hard work of our US team and employees across Xellia. Now that the site is in full working order, we will continue to ramp up our US operations to strengthen our market presence in anti-infective production and help provide the security of supply of vital drug products needed by US hospitals and patients," writes Patrick Brunner, vice president of Manufacturing Operations North America, in a press release.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
CHMP to remove 100 generic medicines from market
Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.
Germany orders 40,000 monkeypox vaccines from Bavarian Nordic
The German Minister for Health has revealed that the German state has ordered vaccines from Bavarian Nordic, as the country reports 5 cases of monkeypox.
New head of research at Astellas Gene Therapies: "Choosing the right indications is extra important"
Morten Søgaard is leaving Pfizer to join Astellas, where he will be in charge of 100 employees. Going from one of the world largest pharmaceutical firms to a considerably smaller one will be a challenge, he says.
Senior Project Manager (GMP - Life Science) 
Biomarker Operations Lead 
Key Account Manager, Europe and Asia 
Senior Manager, Clinical Trial Budget 
Client Talent Acquisition Specialist 
Director for innovative pre-clinical testing unit 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Director of Toxicology 
Director Global Engineering 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Account Manager 
Consultant Manager 
Laboratory technician for process development and clinical manufacturing 
Clinical Project Manager 
Communications Consultant 
Innovation Project Manager, Display Unit 
Production Director